T3D Therapeutics, Inc. Awarded SBIR Phase 2 Grant From The National Institute On Aging For Alzheimer’s Disease Drug Testing

Research Triangle Park, NC (PRWEB) March 24, 2015 T3D Therapeutics, Inc., a Research Triangle Park, NC-based developer of Alzheimer’s disease therapies announced today that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the Company a Small Business Innovation Research (SBIR) Phase 2 grant for the clinical development of ...

AxioMx Receives SBIR Grant to Develop Multiplex Antigen Screening Technology

Branford, Conn. (PRWEB) March 10, 2015 AxioMx Inc., a biotechnology company specializing in the development of high-quality recombinant research antibodies, announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant (1R43GM112385-01). This Phase I award, which will be administered by the National Institute of General ...